Cargando…
Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results
Due to shortages of medical resources during the Coronavirus Disease 2019 (COVID-19) pandemic, an allocation algorithm for Transcatheter Aortic Valve Replacement (TAVR) was established. We investigated the impact on patient selection and procedural results. In total, 456 TAVR patients before (pre-CO...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224926/ https://www.ncbi.nlm.nih.gov/pubmed/35735818 http://dx.doi.org/10.3390/jcdd9060189 |
_version_ | 1784733490715033600 |
---|---|
author | Berisha, Nora Klein, Kathrin Veulemans, Verena Maier, Oliver Piayda, Kerstin Binnebößel, Stephan Afzal, Shazia Polzin, Amin Westenfeld, Ralf Horn, Patrick Jung, Christian Kelm, Malte Quast, Christine Zeus, Tobias |
author_facet | Berisha, Nora Klein, Kathrin Veulemans, Verena Maier, Oliver Piayda, Kerstin Binnebößel, Stephan Afzal, Shazia Polzin, Amin Westenfeld, Ralf Horn, Patrick Jung, Christian Kelm, Malte Quast, Christine Zeus, Tobias |
author_sort | Berisha, Nora |
collection | PubMed |
description | Due to shortages of medical resources during the Coronavirus Disease 2019 (COVID-19) pandemic, an allocation algorithm for Transcatheter Aortic Valve Replacement (TAVR) was established. We investigated the impact on patient selection and procedural results. In total, 456 TAVR patients before (pre-COVID-19 group) and 456 TAVR patients after (COVID-19 group) the implementation of our allocation algorithm were compared. Concerning patient characteristics, the COVID-19 group revealed a higher rate of cardiac decompensations/cardiogenic shocks (10.5% vs. 1.3%; p < 0.001), severe angina pectoris (Canadian Cardiovascular Society (CCS) II, III and IV: 18.7% vs. 11.8%; p = 0.004), troponin elevation (>14 ng/L: 84.9% vs. 77%; p = 0.003) and reduced left ventricular ejection fraction (LVEF) (<45%: 18.9% vs. 12%; p = 0.006). Referring to procedural characteristics, more predilatations (46.3% vs. 35.1%; p = 0.001) and a longer procedural time (80.2 min (+/−29.4) vs. 66.9 min (+/−17.5); p < 0.001) were observed. The success rate was evenly high; no differences in safety parameters were reported. Examining the utilization of hospital resources, the COVID-19 group showed a shorter in-hospital stay (8.4 days (+/−5.9) vs. 9.5 days (+/−9.33); p = 0.041) and fewer TAVR patients were treated per month (39 (+/−4.55) vs. 46.11 (+/−7.57); p = 0.03). Our allocation algorithm supported prioritization of sicker patients with similar efficient and safe TAVR procedures. In-hospital stay could be shortened. |
format | Online Article Text |
id | pubmed-9224926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92249262022-06-24 Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results Berisha, Nora Klein, Kathrin Veulemans, Verena Maier, Oliver Piayda, Kerstin Binnebößel, Stephan Afzal, Shazia Polzin, Amin Westenfeld, Ralf Horn, Patrick Jung, Christian Kelm, Malte Quast, Christine Zeus, Tobias J Cardiovasc Dev Dis Article Due to shortages of medical resources during the Coronavirus Disease 2019 (COVID-19) pandemic, an allocation algorithm for Transcatheter Aortic Valve Replacement (TAVR) was established. We investigated the impact on patient selection and procedural results. In total, 456 TAVR patients before (pre-COVID-19 group) and 456 TAVR patients after (COVID-19 group) the implementation of our allocation algorithm were compared. Concerning patient characteristics, the COVID-19 group revealed a higher rate of cardiac decompensations/cardiogenic shocks (10.5% vs. 1.3%; p < 0.001), severe angina pectoris (Canadian Cardiovascular Society (CCS) II, III and IV: 18.7% vs. 11.8%; p = 0.004), troponin elevation (>14 ng/L: 84.9% vs. 77%; p = 0.003) and reduced left ventricular ejection fraction (LVEF) (<45%: 18.9% vs. 12%; p = 0.006). Referring to procedural characteristics, more predilatations (46.3% vs. 35.1%; p = 0.001) and a longer procedural time (80.2 min (+/−29.4) vs. 66.9 min (+/−17.5); p < 0.001) were observed. The success rate was evenly high; no differences in safety parameters were reported. Examining the utilization of hospital resources, the COVID-19 group showed a shorter in-hospital stay (8.4 days (+/−5.9) vs. 9.5 days (+/−9.33); p = 0.041) and fewer TAVR patients were treated per month (39 (+/−4.55) vs. 46.11 (+/−7.57); p = 0.03). Our allocation algorithm supported prioritization of sicker patients with similar efficient and safe TAVR procedures. In-hospital stay could be shortened. MDPI 2022-06-10 /pmc/articles/PMC9224926/ /pubmed/35735818 http://dx.doi.org/10.3390/jcdd9060189 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Berisha, Nora Klein, Kathrin Veulemans, Verena Maier, Oliver Piayda, Kerstin Binnebößel, Stephan Afzal, Shazia Polzin, Amin Westenfeld, Ralf Horn, Patrick Jung, Christian Kelm, Malte Quast, Christine Zeus, Tobias Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results |
title | Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results |
title_full | Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results |
title_fullStr | Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results |
title_full_unstemmed | Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results |
title_short | Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results |
title_sort | structured allocation of transcatheter aortic valve replacement patients during coronavirus disease 2019 pandemic: impact on patient selection and clinical results |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224926/ https://www.ncbi.nlm.nih.gov/pubmed/35735818 http://dx.doi.org/10.3390/jcdd9060189 |
work_keys_str_mv | AT berishanora structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT kleinkathrin structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT veulemansverena structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT maieroliver structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT piaydakerstin structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT binneboßelstephan structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT afzalshazia structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT polzinamin structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT westenfeldralf structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT hornpatrick structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT jungchristian structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT kelmmalte structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT quastchristine structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults AT zeustobias structuredallocationoftranscatheteraorticvalvereplacementpatientsduringcoronavirusdisease2019pandemicimpactonpatientselectionandclinicalresults |